These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8479612)

  • 21. Cysteamine inhibition of bovine pituitary secretory granule prolactin immunoassayability and release.
    Lorenson MY
    Endocrinology; 1984 Aug; 115(2):728-35. PubMed ID: 6745176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro conditions modify immunoassayability of bovine pituitary prolactin and growth hormone: insights into their secretory granule storage forms.
    Lorenson MY
    Endocrinology; 1985 Apr; 116(4):1399-407. PubMed ID: 3918853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors.
    Srikant CB; Patel YC
    Endocrinology; 1984 Sep; 115(3):990-5. PubMed ID: 6146517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteamine inhibition of prolactin immunoassayability and secretion: studies with aminothiophenols and other analogs.
    Jacobs LS; Lorenson MY
    Endocrinology; 1984 Sep; 115(3):1210-7. PubMed ID: 6430683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRH receptor type 1 mediates continual hypoxia-induced changes of immunoreactive prolactin and prolactin mRNA expression in rat pituitary.
    Xu JF; Chen XQ; Du JZ
    Horm Behav; 2006 Feb; 49(2):181-9. PubMed ID: 16099461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in molecular variants during in vitro transformation and release of prolactin by the pituitary gland of the lactating rat.
    Mena F; Hummelt G; Aguayo D; Clapp C; Martínez de la Escalera G; Morales MT
    Endocrinology; 1992 Jun; 130(6):3365-77. PubMed ID: 1597148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
    Scammell JG; Dannies PS
    Endocrinology; 1984 Mar; 114(3):712-6. PubMed ID: 6697959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraventricular administration of estradiol modulates rat prolactin secretion and synthesis.
    Maeda T; Ikegami H; Sakata M; Yamaguchi M; Wada K; Koike K; Adachi K; Kurachi H; Hirota K; Miyake A
    J Endocrinol Invest; 1996 Oct; 19(9):586-92. PubMed ID: 8957741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal regulation of pituitary glandular kallikrein: a morphometric study.
    Roa JP; Powers CA; Vio CP
    Agents Actions Suppl; 1992; 38 ( Pt 1)():603-8. PubMed ID: 1466301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible oncostatic action of cysteamine on the pituitary glands of oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Oct; 127(1):119-27. PubMed ID: 2103572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin-synthesizing and prolactin-releasing activity of fetal and early postnatal rat pituitaries: in vivo and in vitro studies using RIA, reverse hemolytic plaque assay and immunocytochemistry.
    Nemeskéri A; Acs Z; Tóth BE
    Neuroendocrinology; 1995 Jun; 61(6):687-94. PubMed ID: 7659193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Size and charge heterogeneity of pituitary and plasma prolactin in the male rat.
    Briski KP; Swanson GN; Sylvester PW
    Neuroendocrinology; 1996 May; 63(5):437-45. PubMed ID: 8738581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin (PRL) processing by kallikrein: production of the 21-23.5K PRL-like molecules and inferences about PRL storage in mature secretory granules.
    Ho TW; Balden E; Chao J; Walker AM
    Endocrinology; 1991 Jul; 129(1):184-92. PubMed ID: 2055182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of cysteamine on thyrotropin and immunoreactive beta-endorphin secretion in the rat.
    Millard WJ; Sagar SM; Badger TM; Carr DB; Arnold MA; Spindel E; Kasting NW; Martin JB
    Endocrinology; 1983 Feb; 112(2):518-25. PubMed ID: 6184215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of pituitary prolactin and adrenocortical response to ether, formalin or restraint in lactating rats: rise in corticosterone, but no increase in plasma prolactin levels after exposure to stress.
    Bánky Z; Nagy GM; Halász B
    Neuroendocrinology; 1994 Jan; 59(1):63-71. PubMed ID: 8145895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin messenger ribonucleic acid concentrations in 4-day cycling rats and during the prolactin surge.
    Haisenleder DJ; Ortolano GA; Landefeld TD; Zmeili SM; Marshall JC
    Endocrinology; 1989 Apr; 124(4):2023-8. PubMed ID: 2924734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular mechanisms of estrogen- and dopamine-induced control of glandular kallikrein in the anterior pituitary of the rat.
    Roa JP; Powers CA; Silva R; Vio CP
    Cell Tissue Res; 1993 Dec; 274(3):421-7. PubMed ID: 7507405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential interaction of [35S]cysteamine with pituitary secretory granule storage forms of prolactin.
    Lorenson MY; Jacobs LS
    Neuroendocrinology; 1988 Apr; 47(4):358-64. PubMed ID: 3374761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cysteamine administration on somatostatin biosynthesis and levels in rat hypothalamus.
    Kwok RP; Cameron JL; Faller DV; Fernstrom JD
    Endocrinology; 1992 Dec; 131(6):2999-3009. PubMed ID: 1359964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
    Oomizu S; Boyadjieva N; Sarkar DK
    Alcohol Clin Exp Res; 2003 Jun; 27(6):975-80. PubMed ID: 12824819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.